EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Mycobiome and Asthma

Amjad N Kanj iD, Joseph H Skalski iD

Journal of Fungi · 01.03.2024 · 10 (3) · 192

DOI: 10.3390/jof10030192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Fungi, online erschienen am 01.03.2024. Verfasst von Amjad N Kanj und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review explores the ‘gut–lung axis’ in asthma with a focus on commensal fungal organisms. We explore how changes to the intestinal commensal fungal community composition alter lung immune function. We comprehensively review available studies that have profiled the composition of the gut mycobiome in adults and children with asthma, and discuss mechanisms of gut–lung interactions that have been described in animal models of asthma. Studies indicate that intestinal fungal dysbiosis, such as an increased abundance of certain fungi like Candida, can elevate the risk of asthma in children and exacerbate it in adults. This effect is mediated through various pathways: the host immune system’s sensing of dysbiosis via C-type lectin receptors (e.g., Dectin-2), the impact of pro-inflammatory fungal metabolites (e.g., 12,13-diHOME, prostaglandin E2), and the role of lung immune cells (e.g., group 2 innate lymphoid cells [ILC2], M2 macrophages). We also describe strategies for modulating the gut mycobiome as potential therapies for severe asthma. The review concludes by emphasizing the necessity for further research into the role of the gut mycobiome in asthma to deepen our understanding of these complex interactions.

Schlagwörter

Stichwörter der Autor:innen

Candidaasthmafungal dysbiosisgut mycobiomegut–lung axisimmune pathways

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.

ORCID-Profile: Amjad N Kanj, Joseph H Skalski

Zitieren

APA

Kanj, A. N., & Skalski, J. H. (2024). Gut Mycobiome and Asthma. Journal of Fungi, 10(3), 192. https://doi.org/10.3390/jof10030192

Vancouver

Kanj AN, Skalski JH. Gut Mycobiome and Asthma. Journal of Fungi. 2024;10(3):192. doi:10.3390/jof10030192

BibTeX
@article{Kanj2024,
  author = {Kanj, Amjad N and Skalski, Joseph H},
  title = {Gut Mycobiome and Asthma},
  journal = {Journal of Fungi},
  year = {2024},
  volume = {10},
  number = {3},
  pages = {192},
  doi = {10.3390/jof10030192}
}
Kostenlos starten →